Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1989 1
1992 2
1994 1
1997 6
1998 3
1999 5
2000 6
2001 4
2002 2
2003 1
2004 5
2005 5
2006 3
2007 3
2008 5
2009 1
2010 3
2011 4
2012 8
2013 8
2014 5
2015 4
2016 8
2017 7
2018 7
2019 3
2020 4
2021 4
2022 2
2023 7
2024 14
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Bien dormir, c’est bien grandir !
Toure B. Toure B. Soins Pediatr Pueric. 2024 Sep-Oct;45(340):1. doi: 10.1016/j.spp.2024.06.004. Epub 2024 Aug 1. Soins Pediatr Pueric. 2024. PMID: 39142747 French. No abstract available.
L’enfant et la drépanocytose.
Touré B. Touré B. Soins Pediatr Pueric. 2025 Jul-Aug;46(345):1. doi: 10.1016/j.spp.2025.05.001. Epub 2025 Jun 20. Soins Pediatr Pueric. 2025. PMID: 40645735 French. No abstract available.
Apprentissage et méthodes pédagogiques.
Moronvalle AC, Touré B. Moronvalle AC, et al. Among authors: toure b. Soins Pediatr Pueric. 2025 Jul-Aug;46(345):11-37. doi: 10.1016/j.spp.2025.05.002. Epub 2025 Jun 20. Soins Pediatr Pueric. 2025. PMID: 40645736 French. No abstract available.
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2.
Schönherr H, Ayaz P, Taylor AM, Casaletto JB, Touré BB, Moustakas DT, Hudson BM, Valverde R, Zhao S, O'Hearn PJ, Foster L, Sharon DA, Garfinkle S, Giordanetto F, Lescarbeau A, Kurukulasuriya R, Gerami-Moayed N, Maglic D, Bruderek K, Naik G, Gunaydin H, Mader MM, Boezio AA, McLean TH, Chen R, Wang Y, Shaw DE, Watters J, Bergstrom DA. Schönherr H, et al. Among authors: toure bb. Proc Natl Acad Sci U S A. 2024 Feb 6;121(6):e2317756121. doi: 10.1073/pnas.2317756121. Epub 2024 Feb 1. Proc Natl Acad Sci U S A. 2024. PMID: 38300868 Free PMC article.
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.
Subbiah V, Sahai V, Maglic D, Bruderek K, Touré BB, Zhao S, Valverde R, O'Hearn PJ, Moustakas DT, Schönherr H, Gerami-Moayed N, Taylor AM, Hudson BM, Houde DJ, Pal D, Foster L, Gunaydin H, Ayaz P, Sharon DA, Goyal L, Schram AM, Kamath S, Sherwin CA, Schmidt-Kittler O, Jen KY, Ricard F, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Casaletto JB. Subbiah V, et al. Among authors: toure bb. Cancer Discov. 2023 Sep 6;13(9):2012-2031. doi: 10.1158/2159-8290.CD-23-0475. Cancer Discov. 2023. PMID: 37270847 Free PMC article.
Acceptability, barriers and facilitators of using dried blood spots-point-of-care testing for sickle cell disease in Africa: an implementation science protocol for a multinational qualitative study.
Nnodu OE, Munung NS, Chirande L, Chunda-Liyoka C, Kiguli S, Sarfo FS, Touré BA, Balandya E, Guindo A, Kuona P, Esoh K, Jonas M, Nwegbu M, Masamu U, Morrice J, Moru PO, Bitoungui VN, Nembaware V, Nkya S, Tshilolo L, Makani J, Wonkam A, Peprah E; SickleInAfrica Consortium. Nnodu OE, et al. Among authors: toure ba. BMJ Open. 2024 Nov 7;14(11):e089056. doi: 10.1136/bmjopen-2024-089056. BMJ Open. 2024. PMID: 39515852 Free PMC article.
142 results